Pharma sector got overlooked in the recently announced interim budget though there were some radical announcements for other sectors. The industry continues to await its due. Express Pharma garners a few reactions to the interim budget and looks at Modi government's significant offerings for the sector in the last five years
Budget 2019: What does it hold for India Pharma Inc?
'TO INCENTIVISE INVESTMENT IN R&D, PARTICULARLY IN HEALTHCARE AND PHARMA SECTOR SEVERAL STRATEGIC INPUTS NEED TO BE PROVIDED'
Dr Ajit Dangi, President & CEO, Danssen Consulting
The interim budget 2019 presented by the interimFinance Minister had one eye firmly on the forthcoming general election. While the budget has something for every one from farmers to middle class to Bollywood, it has managed to balance the populist tone with the fiscal prudence reasonably well.
We were hoping to get some fiscal incentives for the start ups and scrapping of the Angel tax , however, this did not happen. While the overall healthcare outlay has been increased by 16 per cent to 54,302.50 crores, it should have been increased in line with the target of 2.5 per cent of GDP as being proposed for the last several years. Also, GST simplification to just two slabs as assured should have been implemented.
Inspite of India being world’s fastest growing economy,our investment in R&D particularly in Science & Technology has stagnated at around 0.65 per cent of GDP for over two decades. To incentivise investment in R&D, particularly in healthcare and pharma sector several strategic inputs need to be provided.
One positive anouncement is the proposed formation of National Centre for Artficial Intelligence. With the US and China leading the AI race, this will go a long way for India to remain competitive in technology sector.
Hopefully, the next full budget will address more such strategically important issues.
IT IS TIME INDUSTRY EXPECTATIONS AND THE GOVERNMENT FOCUS ARE ALIGNED
Anil Khanna, Partner, WisdomSmith
Esta historia es de la edición February 16-28, 2019 de Express Pharma.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición February 16-28, 2019 de Express Pharma.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
MAKING SUSTAINABILITY SUSTAINABLE
Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, MSME pharma companies need to carefully balance their sustainability goals with financial viability
New energy recovery system for tablet coaters
Upto 50 per cent less steam energy consumption
The future of pharma logistics: Trends, challenges, and opportunities
Nikhil Agarwal, President, CJ Darcl Logistics explains that the future of pharma logistics is a thrilling frontier shaped by technological advancements, regulatory challenges, and the imperative of sustainability. As the industry transforms, logistics providers must embrace innovative solutions and adapt to shifting demands
Achieving Aatmanirbharta In APIs Are We On The Right Track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats
Yokogawa launches OpreX Data Model Broker
A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation
Understanding the nuances of generics injectables
At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial
Trending in nutraceuticals: Science meets sustainability
Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe
The growth of e-pharmacies in India
Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these
Xylitol and Maltitol: Low-calorie sugar alternatives
Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste
Single-use TC gaskets and their importance
Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.